May 14, 2025FinancialNotice concerning differences in non-consolidated financial results between FY2023 and FY2024 (PDF 108.74 KB)
May 14, 2025CorporateTerumo and WuXi Biologics Enter into Agreement on a Drug Product Plant in Leverkusen, GermanyExpanding production capacity and global responsiveness of Terumo’s CDMO business
Stories Our Technologies Introducing the Terumo Group’s R&D and production engineering initiatives. #12 Personalized Treatment of Liver Cancer Using Microscopic Radioactive Beads #11 Keeping Hope Alive: The Story of the Terumo Implantable Left Ventricular Assist System #10 "Hybrid" Graft Technologies to Support the Evolution of Aortic Treatment #09 Delivering Efficiency and Quality to Cell Therapy Manufacturing #08 Improving Interventional Treatment Quality Pursuing Intravascular Imaging Technology #07 ICT Healthcare Evolution and the State of Pharmaceutical Infusion Systems #06 Terumo Bay Area Innovation Lab A place to create new value #05 Creating Core Technologies to Contribute into the Future #04 Integrating Technologies to Give Diabetes Patients Lifestyle Freedom #03 Technology that Meets Patients’ Medication Needs with Safety and Certainty #02 Continuously Innovating First-in-class Technology to Support Cardiovascular Surgery #01 Intervention through the Wrist Thirty Years of Evolution; More to Come